131 results match your criteria: "Centre of Gastroenterology[Affiliation]"

Article Synopsis
  • A study examined the occurrence of seroreversion, which is when previously positive anti-hepatitis C virus tests become negative, in patients who responded to antiviral treatment with Interferon and Ribavirin.
  • Out of 30 sustained responders followed for an average of about 55 months, 23% experienced seroreversion, and 25% of them lost anti-HCV antibodies by 56 months post-treatment.
  • The patients who had seroreversion displayed lower CD4+ immune response compared to those who remained positive for anti-HCV antibodies, indicating potential challenges in achieving complete viral eradication in some cases.
View Article and Find Full Text PDF

Objectives: To evaluate the frequency of cholestatic pattern in patients with autoimmune hepatitis (AIH) and to identify predictive factors associated with the development of the overlap syndrome.

Methods: Eighty-two consecutive patients diagnosed with AIH at the referral centre between January 1998 and June 2002 were included in the study. The new scoring system modified by the International Autoimmune Hepatitis Group was used to classify patients as definite/probable.

View Article and Find Full Text PDF

We studied the relationship between immunological markers such as CD4+ proliferation, cytokines profile and lymphocyte activation markers in patients with chronic hepatitis C, having different responses to interferon (IFN) and ribavirin (RBV) treatment. A prospective study of 20 patients was conducted, six had received IFN-alpha-2b alone and 14 IFN in combination with RBV. The proliferative immune responses of peripheral blood mononuclear cells to hepatitis C virus peptides and the lymphocyte activation markers (CD25+, CD38+ and CD69+) were assessed before treatment, at 1 week, and 1, 3 and 6 months of treatment.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess oxidative stress levels in chronic hepatitis C patients before, during, and after treatment with interferon a2b over a year.
  • - Results showed that patients had increased oxidative stress markers before treatment, but there were significant improvements during and after treatment, with notable decreases in certain harmful molecules.
  • - The findings suggest interferon treatment helps reduce oxidative stress and may improve liver activity and fibrosis in chronic hepatitis C patients, highlighting its potential benefits in managing the disease.
View Article and Find Full Text PDF
Article Synopsis
  • A study compared the quality of life of patients who had successful treatment for gallbladder stones through extra-corporeal shock-wave lithotripsy versus those who had cholecystectomy (gallbladder removal).
  • Both groups reported high quality of life scores, but those who received lithotripsy had slightly better scores overall, especially regarding digestive issues like nausea.
  • The findings suggest that while both treatments lead to good outcomes, lithotripsy may result in fewer digestive complaints compared to cholecystectomy, which could lead to a more comfortable recovery.
View Article and Find Full Text PDF

Gastroduodenal tuberculosis is a rare location of abdominal tuberculosis. It usually occurs secondary to pulmonary tuberculosis. We report a case of a 63-year-old woman admitted to the referral center for symptoms of upper gastrointestinal obstruction caused by ulcerohypertrophic antroduodenal tuberculosis.

View Article and Find Full Text PDF

Chemoembolization in the treatment of metastatic ileocolic carcinoid.

Rom J Gastroenterol

June 2002

Centre of Gastroenterology and Hepatology, Fundeni Clinical Institute, Sos. Fundeni no. 258, 72437 Bucharest, Romania.

Carcinoid tumours are enigmatic, slow growing malignancies, which occur most frequently (74%) in the gastrointestinal tract. Symptoms of the carcinoid syndrome (flushing and diarrhoea) are infrequent, occurring in approximately 10% of the patients with small bowel carcinoid. A 45-year-old patient with multiple liver metastases, diagnosed in 1994 with nonHodgkin's lymphoma after undergoing surgery for a distal ileal tumour, was referred to us by the Department of Haematology.

View Article and Find Full Text PDF

Our objective was to verify the presence of prostaglandin-producing suppressor cells in response to hepatitis C virus antigens in peripheral blood mononuclear cells proliferation. Standard proliferation tests were performed in 31 patients: 20 with chronic hepatitis C after antiviral treatment [7 long-term responders (LTR), 7 relapsers (RR), 6 nonresponders (NR)], 7 with HCV infection with persistently normal aminotransferase levels (PNAL), and 4 with hepatocellular carcinoma. Six antigens were used from the core and NS3 regions.

View Article and Find Full Text PDF

Topical mononitrate treatment in patients with anal fissure.

Aliment Pharmacol Ther

January 2002

Clinical Centre of Gastroenterology, State University Hospital Queen Joanna, Sofia, Bulgaria.

Aim: To assess the efficacy and patient compliance of topical mononitrate hydrogel for the treatment of anal fissure.

Materials And Methods: Nineteen patients with symptomatic chronic anal fissures were randomly allocated to receive either active (10 patients) or placebo (nine patients) gel treatment. Rectal administration of hydrogel containing 0.

View Article and Find Full Text PDF

Background: Rectal formulations of mesalazine are the treatment of choice in mildly to moderately active ulcerative colitis. A new foam formulation of mesalazine was developed to improve both drug delivery and patient acceptance.

Methods: In this multicentre, randomized, double-blind, parallel-group study, 111 patients with mildly to moderately active proctitis, proctosigmoiditis, or left-sided ulcerative colitis received mesalazine foam enema or placebo enema (2 g mesalazine per day) for 6 weeks.

View Article and Find Full Text PDF

Objective: The risk of recurrence has limited the acceptability of conservative therapies of gallbladder stones. The aim of the present study was to determine the rate of stone recurrence and its risk factors, after successful shock-wave lithotripsy.

Design: Prospective ultrasound follow-up at yearly intervals or whenever biliary pain was reported.

View Article and Find Full Text PDF

A total of 478 patients with endoscopically confirmed duodenal ulcer entered this randomized, parallel, double-blind trial. Patients were randomly assigned to receive ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene)amino]- 4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-benzenesulfona mid e, CAS 100981-43-9, FI-3542) 400 mg or ranitidine 300 mg tablets (4:1) respectively, administered in single evening doses. Endoscopy, clinical examination and symptom assessment were performed at baseline and at weeks 4 and 8.

View Article and Find Full Text PDF

Immune complexes were detected by radioimmunoassay in colonic tissue from 71 to 122 patients (58%) excreting Entamoeba histolytica cysts and in liver tissue from 5 of 16 of these patients. Complexes were also found in colonic tissue from 9 of 56 other patients (16%) who were not excreting cysts.

View Article and Find Full Text PDF

Zymodeme alteration of Entamoeba histolytica isolates under varying conditions.

Trans R Soc Trop Med Hyg

December 1993

Kothari Centre of Gastroenterology, Kothari Medical Centre, Calcutta, India.

Cysts of Entamoeba histolytica obtained from 2 asymptomatic subjects were cloned in vitro and the isoenzyme patterns and virulence of the cultures derived from them were determined. Incubation in Diamond's TYI-S-33 medium with Crithidia sp. for 80 d resulted in a change from zymodeme III to zymodeme II, with consistent virulence.

View Article and Find Full Text PDF

High cell surface hydrophobicity of virulent Entamoeba histolytica isolates.

Trans R Soc Trop Med Hyg

December 1992

Kothari Centre of Gastroenterology, Kothari Medical Centre, Calcutta, India.

Thirty isolates of Entamoeba histolytica were examined for their cell surface hydrophobicity. It was observed that increased hydrophobicity of the trophozoites was associated with lesion-forming ability in hamster liver, a higher rate of erythrophagocytosis and greater resistance to complement. The relationship of cell surface hydrophobicity to other virulence markers in E.

View Article and Find Full Text PDF

1. The zymodeme and virulence of 31 Entamoeba histolytica isolates obtained from asymptomatic human subjects in Calcutta, India are described. 2.

View Article and Find Full Text PDF

Gallbladder wall thickening was detected by ultrasonography in 3.5% of 3900 patients. Wall thickening was observed not only in cholecystitis but also in cases of diffuse liver diseases, in patients with syndrome of portal hypertension, as well as in chronic heart insufficiency and other pathologies.

View Article and Find Full Text PDF

Enhancement of the virulence of five strains of Entamoeba histolytica (three xenically maintained and two axenically maintained) was studied after in vitro incubation with normal hamster liver. Increased virulence was shown by the ability of a small number of liver-treated trophozoites to produce liver lesions in hamsters. Enhancement of virulence was positively correlated with increased resistance to normal hamster serum complement in vitro.

View Article and Find Full Text PDF

Entamoeba histolytica isolates, obtained mainly from asymptomatic human cyst passers, were tested for their in vitro erythrophagocytic activity and lesion-forming ability in hamster liver. Simultaneous zymodeme typing of the isolates showed that, along with the pathogenic zymodemes, a number of isolates having nonpathogenic zymodemes also produced liver lesions in hamsters and engulfed higher numbers of RBCs. The observed positive correlation between the rate of erythrophagocytosis of an E.

View Article and Find Full Text PDF

We report a 12 year old boy of Nepalese origin with gastric adenocarcinoma and associated nodular lymphoid hyperplasia of the colon, with hemoglobin E trait and normal serum immunoglobulins. The boy underwent a curative resection and is free of recurrence or metastasis nine months after diagnosis.

View Article and Find Full Text PDF